Cargando…
Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear
BACKGROUND: Intratympanic injections of glucocorticoids have become increasingly common in the treatment of idiopathic sudden sensorineural hearing loss (ISSHL). However, due to their fast elimination, sustained applications have been suggested for local drug delivery to the inner ear. MATERIALS AND...
Autores principales: | Plontke, Stefan K., Liebau, Arne, Lehner, Eric, Bethmann, Daniel, Mäder, Karsten, Rahne, Torsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530574/ https://www.ncbi.nlm.nih.gov/pubmed/36203796 http://dx.doi.org/10.3389/fnins.2022.892777 |
Ejemplares similares
-
Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear
por: Lehner, Eric, et al.
Publicado: (2021) -
Metabolic reprogramming of inner ear cell line HEI-OC1 after dexamethasone application
por: Kather, Michel, et al.
Publicado: (2021) -
Intracochlear PLGA based implants for dexamethasone release: Challenges and solutions
por: Lehner, E., et al.
Publicado: (2019) -
Influence of Hearing Rehabilitation With Active Middle Ear and Bone Conduction Implants on Postural Control
por: Seiwerth, Ingmar, et al.
Publicado: (2022) -
Intratympanic corticosteroids for sudden sensorineural hearing loss
por: Plontke, Stefan K, et al.
Publicado: (2022)